DA Davidson raised the firm’s price target on Vital Farms to $45 from $28 and keeps a Buy rating on the shares after its Q1 EBITDA beat. The company is the “most likely beat and raise candidate” over the balance of 2024 in the analyst’s coverage universe, the firm tells investors in a research note, adding however that the stock’s valuation now better reflects Vital Farms’ financial profile.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VITL:
